No. | Position (bps) This study | Similar to position (bp) | Comments | Ref. No. |
---|---|---|---|---|
1. | -545 to -368 | -537 to -367 | In vivo, in the presence of bound TFIIIC | 39 |
2. | -368 to -78 | -367 to -214 | In vivo, in the presence of bound TFIIIC | 39 |
3. | -656 to -453 | Â | In vitro, sequence-directed | Â |
4. | -453 to -241 | Â | In vitro, sequence-directed | Â |
5. | -241 to -78 | -240 to -70 | In vivo, in the presence of bound TFIIIC | 37 |
6. | -125 to +25 | -194 to -16 | In vivo, in the absence of bound TFIIIC | 39 |
 |  | -120 to +28 | In vivo, under repression | 37 |
7. | -110 to +45 | -116 to +40 | Predicted | 26 |
8. | -90 to +65 | Positions 8–10 together as bp -78 to + 110 in the plasmid | ||
9. | -60 to +95 | p-539H6, Figure 1B, sequence-directed. | ||
10. | -40 to +115 | Positions 9–15 together as bp -50 to + 316 in the plasmid | ||
11. | -20 to +125 | pCS6, Figure 1C, sequence-directed. | ||
12. | +51 to +196 | +48 to +192 | In vitro, TFIIIC-dependent | 3 |
 |  | +94 to +198 | In vivo, in the presence of bound TFIIIC | 59 |
13. | +71 to +216 | +71 to +227 | Predicted | 26 |
 |  | +85 to +206 | In vivo, in the absence of bound TFIIIC | 39 |
14. | +91 to +236 | Â | In vitro, sequence-directed | Â |
15. | +101 to +256 | Â | In vitro, sequence-directed | Â |